‘Swift Evaluation’ on new drugs approved for the first time in Korea
The government will push forward with a measure for newly-approved new drugs for the first time in Korea to pass insurance benefit propriety evaluations within 100 days in Korea. It has decided to introduce the so-called ‘Fast Track.’
When it comes to innovative pharmaceutical companies, it will...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
